首页 > 最新文献

Official Journal of the Association of Medical Microbiology and Infectious Disease Canada最新文献

英文 中文
Do family medicine residents optimally prescribe antibiotics for common infectious conditions seen in a primary care setting? 家庭医疗住院医师是否对初级保健环境中常见的感染性疾病处方抗生素?
Pub Date : 2023-11-29 eCollection Date: 2023-11-01 DOI: 10.3138/jammi-2022-0042
Bernard Ho, Sahana Kukan, Warren McIsaac

Background: Antimicrobial resistance is a worldwide phenomenon that leads to a significant number of unnecessary deaths and costly hospital admissions. More than 90% of antibiotic use happens in the community and of this, family physicians account for two-thirds of these prescriptions. Our study aims to determine whether family medicine residents are optimally trained in antibiotic prescribing for common infectious conditions seen in a primary care setting.

Methods: This study is a secondary analysis of a prior study of antimicrobial stewardship in two urban primary care clinics in central Toronto, Ontario. A total of 1099 adult patient visits were included that involved family medicine resident trainees, seen between 2015 and 2016. The main outcome measures were resident antibiotic prescription rates for each condition and expert-recommended prescribing practices, the rate prescriptions were issued as delayed prescriptions, and the use of first-line recommended narrow-spectrum antibiotics.

Results: Compared to expert-recommended prescribing rates, family medicine residents overprescribed for uncomplicated upper respiratory tract infections (URI) (5.0% [95% CI 2.2% to 9.7%] versus 0% expert recommended) and sinusitis (44.2% [95% CI 32.8% to 55.9%] versus 11%-18% expert range), and under prescribed for pneumonia (53.5% [95% CI 37.7% to 68.8%] versus 100% expert range]). Prescribing rates were within expert recommended ranges for pharyngitis (28.6% [95% CI 16.6% to 43.3%]), bronchitis (3.6% [95% CI 0% to 18.4%]), and cystitis (79.4% [95% CI 70.6% to 86.6%]).

Conclusions: The antibiotic prescribing practices of family medicine residents during their training programs indicated overprescribing of antibiotics for some common infection presentations. Further study of antibiotic prescribing in primary care training programs across Canada is recommended to determine if future family physicians are learning appropriate antibiotic prescribing practices.

背景:抗菌素耐药性是一种世界范围的现象,导致大量不必要的死亡和昂贵的住院费用。超过90%的抗生素使用发生在社区,其中,家庭医生占这些处方的三分之二。我们的研究旨在确定家庭医学居民是否在初级保健环境中对常见传染病的抗生素处方进行了最佳培训。方法:本研究是对安大略省多伦多市中心两个城市初级保健诊所抗菌药物管理的先前研究的二次分析。2015年至2016年间,共有1099名成人患者就诊,涉及家庭医学住院医师实习生。主要观察指标为各病种的住院抗生素处方率和专家推荐处方做法、延迟开具处方率和一线推荐窄谱抗生素的使用情况。结果:与专家推荐的处方率相比,家庭医学居民在无并发症上呼吸道感染(URI) (5.0% [95% CI 2.2%至9.7%],专家推荐为0%)和鼻窦炎(44.2% [95% CI 32.8%至55.9%],专家范围为11%-18%)和肺炎(53.5% [95% CI 37.7%至68.8%],专家范围为100%)的处方率过高。咽炎(28.6% [95% CI 16.6% ~ 43.3%])、支气管炎(3.6% [95% CI 0% ~ 18.4%])和膀胱炎(79.4% [95% CI 70.6% ~ 86.6%])的处方率均在专家推荐范围内。结论:家庭医学住院医师在培训期间的抗生素处方实践表明,一些常见感染的抗生素处方过量。建议对加拿大初级保健培训项目中的抗生素处方进行进一步研究,以确定未来的家庭医生是否正在学习适当的抗生素处方实践。
{"title":"Do family medicine residents optimally prescribe antibiotics for common infectious conditions seen in a primary care setting?","authors":"Bernard Ho, Sahana Kukan, Warren McIsaac","doi":"10.3138/jammi-2022-0042","DOIUrl":"10.3138/jammi-2022-0042","url":null,"abstract":"<p><strong>Background: </strong>Antimicrobial resistance is a worldwide phenomenon that leads to a significant number of unnecessary deaths and costly hospital admissions. More than 90% of antibiotic use happens in the community and of this, family physicians account for two-thirds of these prescriptions. Our study aims to determine whether family medicine residents are optimally trained in antibiotic prescribing for common infectious conditions seen in a primary care setting.</p><p><strong>Methods: </strong>This study is a secondary analysis of a prior study of antimicrobial stewardship in two urban primary care clinics in central Toronto, Ontario. A total of 1099 adult patient visits were included that involved family medicine resident trainees, seen between 2015 and 2016. The main outcome measures were resident antibiotic prescription rates for each condition and expert-recommended prescribing practices, the rate prescriptions were issued as delayed prescriptions, and the use of first-line recommended narrow-spectrum antibiotics.</p><p><strong>Results: </strong>Compared to expert-recommended prescribing rates, family medicine residents overprescribed for uncomplicated upper respiratory tract infections (URI) (5.0% [95% CI 2.2% to 9.7%] versus 0% expert recommended) and sinusitis (44.2% [95% CI 32.8% to 55.9%] versus 11%-18% expert range), and under prescribed for pneumonia (53.5% [95% CI 37.7% to 68.8%] versus 100% expert range]). Prescribing rates were within expert recommended ranges for pharyngitis (28.6% [95% CI 16.6% to 43.3%]), bronchitis (3.6% [95% CI 0% to 18.4%]), and cystitis (79.4% [95% CI 70.6% to 86.6%]).</p><p><strong>Conclusions: </strong>The antibiotic prescribing practices of family medicine residents during their training programs indicated overprescribing of antibiotics for some common infection presentations. Further study of antibiotic prescribing in primary care training programs across Canada is recommended to determine if future family physicians are learning appropriate antibiotic prescribing practices.</p>","PeriodicalId":19454,"journal":{"name":"Official Journal of the Association of Medical Microbiology and Infectious Disease Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697098/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84863072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The lower Saint Lawrence River region of Quebec, a hot spot for sheepfold-associated Q fever in Canada: Review of 258 cases. 魁北克圣劳伦斯河下游地区,加拿大羊圈相关Q热的热点:258例回顾。
Pub Date : 2023-11-29 eCollection Date: 2023-11-01 DOI: 10.3138/jammi-2023-0001
Patrick Dolcé, Annie de Beaumont-Dupont, Philippe Jutras, Florence Mailhot-Léonard, Maria Alexandra Rosca, Joanne Aubé-Maurice

Background: The lower Saint Lawrence river region (LSLRR), in Quebec, has a 10-fold higher incidence of Q fever compared to the provincial rate. This study aimed to review clinical cases and the Q fever risk exposure in this region.

Methods: Data were retrieved from microbiology laboratory, medical records from Rimouski Regional Hospital and Public Health reports between 1991 and 2018. They were analyzed with Epi Info 7.2.2.6. Patients with confirmed acute, probable acute, and chronic Q fever were classified using standard case definitions and mapped according to the postal code, to assess the correlation between cases and sheep distribution.

Results: Out of 295 cases, 258 were included (241 confirmed acute, seven probable acute, 10 chronic). Median age was 49 years, 76% were male. For acute cases, the prominent symptoms were fever (99%), headache (83%), chills (80%), sweating (72%), myalgia (69%), and fatigue (67%). Clinical presentation was mostly febrile syndrome with mild hepatitis (84%). A seasonal peak was observed from May to July (56% of acute cases). Most cases (56%) occurred within the two counties where sheep production was highest. Exposure to sheep was prominent 93%, including 64% direct contact (15% shepherds, 49% sheepfold visitors), 14% indirect contact, and 15% sheepfold neighbors.

Conclusions: To our knowledge, this is one of the largest retrospective studies of Q fever cases reported in Canada. Q fever in Quebec LSLRR is associated mainly with sheep exposure. Fever and hepatitis were the most common manifestations. Preventive measures should be considered in this region to protect sheepfold workers, visitors, and their neighbors.

背景:魁北克省圣劳伦斯河下游地区(LSLRR)的Q热发病率比全省高10倍。本研究旨在回顾该地区的临床病例和Q热风险暴露情况。方法:数据来源于微生物实验室、Rimouski地区医院1991 - 2018年的医疗记录和公共卫生报告。使用Epi Info 7.2.2.6进行分析。使用标准病例定义对确诊的急性、可能急性和慢性Q热患者进行分类,并根据邮政编码绘制地图,以评估病例与绵羊分布之间的相关性。结果:共纳入295例病例258例(确诊急性241例,疑似急性7例,慢性10例)。中位年龄49岁,76%为男性。急性病例的主要症状为发热(99%)、头痛(83%)、发冷(80%)、出汗(72%)、肌痛(69%)和疲劳(67%)。临床表现多为发热综合征伴轻度肝炎(84%)。5月至7月为季节性高峰(56%的急性病例)。大多数病例(56%)发生在羊产量最高的两个县。与羊的接触占93%,其中直接接触占64%(牧羊人占15%,羊圈游客占49%),间接接触占14%,羊圈邻居占15%。结论:据我们所知,这是加拿大报道的Q热病例中最大的回顾性研究之一。魁北克LSLRR的Q热主要与绵羊接触有关。发热和肝炎是最常见的表现。该地区应考虑采取预防措施,保护羊圈工作人员、访客及其邻居。
{"title":"The lower Saint Lawrence River region of Quebec, a hot spot for sheepfold-associated Q fever in Canada: Review of 258 cases.","authors":"Patrick Dolcé, Annie de Beaumont-Dupont, Philippe Jutras, Florence Mailhot-Léonard, Maria Alexandra Rosca, Joanne Aubé-Maurice","doi":"10.3138/jammi-2023-0001","DOIUrl":"10.3138/jammi-2023-0001","url":null,"abstract":"<p><strong>Background: </strong>The lower Saint Lawrence river region (LSLRR), in Quebec, has a 10-fold higher incidence of Q fever compared to the provincial rate. This study aimed to review clinical cases and the Q fever risk exposure in this region.</p><p><strong>Methods: </strong>Data were retrieved from microbiology laboratory, medical records from Rimouski Regional Hospital and Public Health reports between 1991 and 2018. They were analyzed with Epi Info 7.2.2.6. Patients with confirmed acute, probable acute, and chronic Q fever were classified using standard case definitions and mapped according to the postal code, to assess the correlation between cases and sheep distribution.</p><p><strong>Results: </strong>Out of 295 cases, 258 were included (241 confirmed acute, seven probable acute, 10 chronic). Median age was 49 years, 76% were male. For acute cases, the prominent symptoms were fever (99%), headache (83%), chills (80%), sweating (72%), myalgia (69%), and fatigue (67%). Clinical presentation was mostly febrile syndrome with mild hepatitis (84%). A seasonal peak was observed from May to July (56% of acute cases). Most cases (56%) occurred within the two counties where sheep production was highest. Exposure to sheep was prominent 93%, including 64% direct contact (15% shepherds, 49% sheepfold visitors), 14% indirect contact, and 15% sheepfold neighbors.</p><p><strong>Conclusions: </strong>To our knowledge, this is one of the largest retrospective studies of Q fever cases reported in Canada. Q fever in Quebec LSLRR is associated mainly with sheep exposure. Fever and hepatitis were the most common manifestations. Preventive measures should be considered in this region to protect sheepfold workers, visitors, and their neighbors.</p>","PeriodicalId":19454,"journal":{"name":"Official Journal of the Association of Medical Microbiology and Infectious Disease Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697106/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82139990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early diagnosis of monomicrobial Clostridioides difficile bacteremia in a patient without colitis. 无结肠炎患者单菌艰难梭菌血症的早期诊断。
Pub Date : 2023-11-29 eCollection Date: 2023-11-01 DOI: 10.3138/jammi-2022-0014
Jennifer Tat, Sigmund Krajden, Samir N Patel, Greg J German

Bacteremia is a rare finding among Clostridioides difficile infections. We describe a case of a 67-year-old man with resected colorectal cancer with colostomy who presented with small bowel obstruction and was admitted for lysis of adhesions. On day 8 of admission, he developed leukocytosis and raised inflammatory markers with isolation of Gram-positive bacilli in several blood cultures, which was presumptively identified through blood culture pelleting and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) as C. difficile. The diagnosis was confirmed with conventional culture and reference lab identification and the patient demonstrated clinical response with parenteral then oral vancomycin that briefly worsened when therapy was switched to parenteral metronidazole and then improved once oral vancomycin was resumed. Our case was notable in that the combination of pelleting and MALDI-TOF offered early diagnosis in this patient whose positive blood cultures were suspicious for contamination and in whom there was an absence of diarrheal illness or features of colitis on abdominal imaging. Early diagnosis is critical for the timely initiation of therapy, implementation of infection prevention and control measures and in selection of appropriate therapy for antimicrobial stewardship.

菌血症在艰难梭菌感染中是一种罕见的发现。我们描述了一个病例67岁的男子切除结直肠癌结肠造口谁提出了小肠梗阻和入院的粘连溶解。入院第8天,患者出现白细胞增多,并在数个血液培养中分离出革兰氏阳性杆菌,炎症标志物升高,通过血液培养颗粒和基质辅助激光解吸/电离飞行时间(MALDI-TOF)推测为艰难梭菌。通过常规培养和参考实验室鉴定证实了诊断,患者在静脉注射万古霉素后表现出临床反应,当治疗转为静脉注射甲硝唑时,病情短暂恶化,然后在恢复口服万古霉素后好转。我们的病例值得注意的是,结合颗粒和MALDI-TOF为该患者提供了早期诊断,该患者的阳性血培养可疑为污染,并且在腹部影像学上没有腹泻疾病或结肠炎的特征。早期诊断对于及时开始治疗、实施感染预防和控制措施以及选择适当的抗微生物药物管理治疗至关重要。
{"title":"Early diagnosis of monomicrobial <i>Clostridioides difficile</i> bacteremia in a patient without colitis.","authors":"Jennifer Tat, Sigmund Krajden, Samir N Patel, Greg J German","doi":"10.3138/jammi-2022-0014","DOIUrl":"10.3138/jammi-2022-0014","url":null,"abstract":"<p><p>Bacteremia is a rare finding among <i>Clostridioides difficile</i> infections. We describe a case of a 67-year-old man with resected colorectal cancer with colostomy who presented with small bowel obstruction and was admitted for lysis of adhesions. On day 8 of admission, he developed leukocytosis and raised inflammatory markers with isolation of Gram-positive bacilli in several blood cultures, which was presumptively identified through blood culture pelleting and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) as <i>C. difficile</i>. The diagnosis was confirmed with conventional culture and reference lab identification and the patient demonstrated clinical response with parenteral then oral vancomycin that briefly worsened when therapy was switched to parenteral metronidazole and then improved once oral vancomycin was resumed. Our case was notable in that the combination of pelleting and MALDI-TOF offered early diagnosis in this patient whose positive blood cultures were suspicious for contamination and in whom there was an absence of diarrheal illness or features of colitis on abdominal imaging. Early diagnosis is critical for the timely initiation of therapy, implementation of infection prevention and control measures and in selection of appropriate therapy for antimicrobial stewardship.</p>","PeriodicalId":19454,"journal":{"name":"Official Journal of the Association of Medical Microbiology and Infectious Disease Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10697101/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72565792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A retrospective review of empiric acyclovir prescribing practices for suspected viral central nervous system infections: A single-centre study. 对疑似病毒性中枢神经系统感染经验性阿昔洛韦处方的回顾性研究:单中心研究。
Pub Date : 2023-09-18 eCollection Date: 2023-09-01 DOI: 10.3138/jammi-2022-0031
JeongMin Marie Kim, Cesilia Nishi, Jennifer Mina Grant

Background: Acyclovir has an important role in the treatment of viral central nervous system (CNS) infection, especially herpes simplex virus (HSV)-1 encephalitis. It is therefore used broadly as empiric therapy for many patients who present to the hospital with symptoms of a possible neurologic infection. We sought to review our practices in acyclovir prescribing, deprescribing, and associated investigations for the clinical syndromes it treats.

Methods: Through a retrospective chart review, we identified patients prescribed acyclovir for a possible CNS infection upon admission to Vancouver General Hospital between January 1, 2019, and December 31, 2019. Patient demographics, signs, symptoms, and comorbidities were taken from admission consultation notes or discharge summaries; their investigations, including laboratory tests and imaging, were also recorded. The primary purpose was to describe the appropriateness of empiric acyclovir use in suspected meningoencephalitis cases.

Results: Among the 108 patients treated with acyclovir, 94 patients had an indication for starting empiric treatment for encephalitis or meningitis. There was suspicion and workup for encephalitis alone in 76 patients. Among discharge diagnoses, the most common was delirium of a different identified source (18 cases), followed by unknown/other (15 cases). There were seven patients whose CSF viral PCR test was positive for HSV or varicella-zoster virus (VZV); three of them had HSV-1 encephalitis. There were two total adverse events recorded attributed to acyclovir; both cases were of mild acute kidney injury.

Conclusion: We found that in many patients, acyclovir was not necessary or could have been stopped earlier, avoiding toxicity and drug costs.

背景:阿昔洛韦在治疗病毒性中枢神经系统(CNS)感染,尤其是单纯疱疹病毒(HSV)-1脑炎方面发挥着重要作用。因此,阿昔洛韦被广泛用作经验疗法,用于治疗许多出现神经系统感染症状的患者。我们试图回顾我们在阿昔洛韦处方、停药以及对其治疗的临床综合征进行相关检查方面的做法:通过回顾性病历审查,我们确定了在 2019 年 1 月 1 日至 2019 年 12 月 31 日期间入住温哥华综合医院的因可能中枢神经系统感染而开具阿昔洛韦处方的患者。患者的人口统计学特征、体征、症状和合并症均取自入院会诊记录或出院摘要;患者的检查项目,包括实验室检查和影像学检查也被记录在案。主要目的是描述在疑似脑膜脑炎病例中经验性使用阿昔洛韦的适当性:结果:在接受阿昔洛韦治疗的 108 名患者中,有 94 名患者有开始经验性治疗脑炎或脑膜炎的指征。76名患者仅怀疑并检查出脑炎。在出院诊断中,最常见的是来源不明的谵妄(18 例),其次是不明/其他(15 例)。有 7 名患者的 CSF 病毒 PCR 检测呈 HSV 或水痘-带状疱疹病毒 (VZV) 阳性,其中 3 人患有 HSV-1 型脑炎。阿昔洛韦导致的不良反应共有两例,均为轻度急性肾损伤:我们发现,在许多患者中,阿昔洛韦是不必要的,或者可以提前停用,从而避免毒性和药物成本。
{"title":"A retrospective review of empiric acyclovir prescribing practices for suspected viral central nervous system infections: A single-centre study.","authors":"JeongMin Marie Kim, Cesilia Nishi, Jennifer Mina Grant","doi":"10.3138/jammi-2022-0031","DOIUrl":"10.3138/jammi-2022-0031","url":null,"abstract":"<p><strong>Background: </strong>Acyclovir has an important role in the treatment of viral central nervous system (CNS) infection, especially herpes simplex virus (HSV)-1 encephalitis. It is therefore used broadly as empiric therapy for many patients who present to the hospital with symptoms of a possible neurologic infection. We sought to review our practices in acyclovir prescribing, deprescribing, and associated investigations for the clinical syndromes it treats.</p><p><strong>Methods: </strong>Through a retrospective chart review, we identified patients prescribed acyclovir for a possible CNS infection upon admission to Vancouver General Hospital between January 1, 2019, and December 31, 2019. Patient demographics, signs, symptoms, and comorbidities were taken from admission consultation notes or discharge summaries; their investigations, including laboratory tests and imaging, were also recorded. The primary purpose was to describe the appropriateness of empiric acyclovir use in suspected meningoencephalitis cases.</p><p><strong>Results: </strong>Among the 108 patients treated with acyclovir, 94 patients had an indication for starting empiric treatment for encephalitis or meningitis. There was suspicion and workup for encephalitis alone in 76 patients. Among discharge diagnoses, the most common was delirium of a different identified source (18 cases), followed by unknown/other (15 cases). There were seven patients whose CSF viral PCR test was positive for HSV or varicella-zoster virus (VZV); three of them had HSV-1 encephalitis. There were two total adverse events recorded attributed to acyclovir; both cases were of mild acute kidney injury.</p><p><strong>Conclusion: </strong>We found that in many patients, acyclovir was not necessary or could have been stopped earlier, avoiding toxicity and drug costs.</p>","PeriodicalId":19454,"journal":{"name":"Official Journal of the Association of Medical Microbiology and Infectious Disease Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10795701/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86327760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brief report of complicated Yersinia enterocolitica infection in an immunocompetent host: Review of the literature and pathogenicity mechanisms. 免疫功能健全的宿主感染复杂的小肠结肠耶尔森菌的简要报告:文献综述和致病机制。
Pub Date : 2023-09-18 eCollection Date: 2023-09-01 DOI: 10.3138/jammi-2022-0019
Sunil Samnani, Helen Bibby, LeeAnne Luft

Background: We report a case of a 47-year-old male presenting with Yersinia enterocolitica septicemia with no known risk factors for invasive infection, found to have multiloculated liver and splenic abscesses with an antecedent history of mild enterocolitis.

Case presentation: Our patient presented with septic shock in the setting of gastroenteritis with abdominal pain and fever. On work-up, he was found to have multiloculated hepatic and splenic abscesses secondary to Y. enterocolitica. No identifiable risk factors (ie, iron-overload syndrome or immunosuppression) for Y. enterocolitica septicemia were identified in our patient. Our patient was treated with a prolonged course of antibiotics until imaging resolution of his liver and splenic abscesses.

Conclusion: Invasive Y. enterocolitica in an immunocompetent host is rare. Our case highlights the pathogenicity of Y. enterocolitica, and important treatment and management considerations.

背景:我们报告了一例 47 岁男性小肠结肠炎耶尔森菌败血症患者的病例,该患者没有已知的侵袭性感染危险因素,被发现患有多灶性肝脾脓肿,之前有轻度小肠结肠炎病史:患者因腹痛、发热并伴有胃肠炎而出现脓毒性休克。经检查发现,他患有继发于小肠结肠炎的多发性肝脾脓肿。在我们的患者中,没有发现导致小肠结肠炎败血症的可识别风险因素(即铁过载综合征或免疫抑制)。我们的患者接受了长期的抗生素治疗,直到肝脏和脾脏脓肿影像学消退:结论:免疫功能正常的宿主感染侵入性小肠结肠炎酵母菌并不多见。我们的病例强调了小肠结肠炎病毒的致病性,以及治疗和管理方面的重要注意事项。
{"title":"Brief report of complicated <i>Yersinia enterocolitica</i> infection in an immunocompetent host: Review of the literature and pathogenicity mechanisms.","authors":"Sunil Samnani, Helen Bibby, LeeAnne Luft","doi":"10.3138/jammi-2022-0019","DOIUrl":"10.3138/jammi-2022-0019","url":null,"abstract":"<p><strong>Background: </strong>We report a case of a 47-year-old male presenting with <i>Yersinia enterocolitica</i> septicemia with no known risk factors for invasive infection, found to have multiloculated liver and splenic abscesses with an antecedent history of mild enterocolitis.</p><p><strong>Case presentation: </strong>Our patient presented with septic shock in the setting of gastroenteritis with abdominal pain and fever. On work-up, he was found to have multiloculated hepatic and splenic abscesses secondary to <i>Y. enterocolitica</i>. No identifiable risk factors (ie, iron-overload syndrome or immunosuppression) for <i>Y. enterocolitica</i> septicemia were identified in our patient. Our patient was treated with a prolonged course of antibiotics until imaging resolution of his liver and splenic abscesses.</p><p><strong>Conclusion: </strong>Invasive <i>Y. enterocolitica</i> in an immunocompetent host is rare. Our case highlights the pathogenicity of <i>Y. enterocolitica</i>, and important treatment and management considerations.</p>","PeriodicalId":19454,"journal":{"name":"Official Journal of the Association of Medical Microbiology and Infectious Disease Canada","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10795698/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73667420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Official Journal of the Association of Medical Microbiology and Infectious Disease Canada
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1